Active Ingredients
Salicylic Acid 2%
The following Structured Product Label (SPL) was submitted to the FDA by Valley Of The Sun Cosmetics Llc for the product Salicylacne-2% Clearing Serum (NDC 76523-020). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, uses, warning, do not use, when using this product, stop use and ask doctor, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Salicylic Acid 2%
Acne Treatment
Use for treatment of acne
For external use only
Allergy Alert: Do not use this product if you have a known allergy to salicylic acid.
Skin irritation and dryness is more likely occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Avoid contact with eyes. If contact occurs, flush thoroughly with water.
If irritation or sensitivity occurs, stop use of product and consult doctor.
If swallowed, get medical help or contact a Poison Control Center right away.
Clean the skin thoroughly before applying this product. Apply affected area with a thin layer, avoiding eye area. Allow to absorb before applying additional products. Can be used twice daily or as directed by a doctor.
Water (aqua), vegetable (kosher) glycerin, propylene glycol (kosher), alcohol, retinol (vitamin A), tocopheryl acetate (vitamin E), azelaic acid, gluthathione, lactic acid, sodium ascorbyl phosphate (Vitamin C), carica papaya (papaya) fruit extract, citrus paradise (*organic grapefruit) fruit extract, citrus medica limonum (*organic lemon) extract, bromelain (*pineapple stem leaf), sulfur, sodium PCA, PPG-5-Ceteth-20, PEG-40 hydrogenated (castor oil), potassium sorbate, phenoxyethanol, hydroxyethylcellulose, carbomer, citric acid, sodium hydroxide
* Please review the disclaimer below.